Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

75 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Thrombopoietin receptor agonists increase splenic regulatory T-cell numbers in immune thrombocytopenia.
Pizzi M, Vianello F, Binotto G, Vianelli N, Carli G, Auteri G, Nichele I, Sbaraglia M, Zoletto S, Scarmozzino F, Bresciani R, d'Amore F, Friziero A, Guzzardo V, Bertozzi I, Famengo B, d'Amore ESG, Sabattini E, Dei Tos AP. Pizzi M, et al. Among authors: bertozzi i. Br J Haematol. 2022 Sep;198(5):916-922. doi: 10.1111/bjh.18309. Epub 2022 Jun 14. Br J Haematol. 2022. PMID: 35701886
Bone marrow histology for the diagnosis of essential thrombocythemia in children: a multicenter Italian study.
Putti MC, Pizzi M, Bertozzi I, Sabattini E, Micalizzi C, Farruggia P, Ramenghi U, Cesaro S, Russo G, Peroni E, Rugge M, Fabris F, Randi ML. Putti MC, et al. Among authors: bertozzi i. Blood. 2017 Jun 1;129(22):3040-3042. doi: 10.1182/blood-2017-01-761767. Epub 2017 Apr 13. Blood. 2017. PMID: 28408463 Free article. Clinical Trial. No abstract available.
Benefit-risk profile of cytoreductive drugs along with antiplatelet and antithrombotic therapy after transient ischemic attack or ischemic stroke in myeloproliferative neoplasms.
De Stefano V, Carobbio A, Di Lazzaro V, Guglielmelli P, Iurlo A, Finazzi MC, Rumi E, Cervantes F, Elli EM, Randi ML, Griesshammer M, Palandri F, Bonifacio M, Hernandez-Boluda JC, Cacciola R, Miroslava P, Carli G, Beggiato E, Ellis MH, Musolino C, Gaidano G, Rapezzi D, Tieghi A, Lunghi F, Loscocco GG, Cattaneo D, Cortelezzi A, Betti S, Rossi E, Finazzi G, Censori B, Cazzola M, Bellini M, Arellano-Rodrigo E, Bertozzi I, Sadjadian P, Vianelli N, Scaffidi L, Gomez M, Cacciola E, Vannucchi AM, Barbui T. De Stefano V, et al. Among authors: bertozzi i. Blood Cancer J. 2018 Feb 28;8(3):25. doi: 10.1038/s41408-018-0048-9. Blood Cancer J. 2018. PMID: 29535299 Free PMC article. Clinical Trial.
The Aspirin Regimens in Essential Thrombocythemia (ARES) phase II randomized trial design: Implementation of the serum thromboxane B2 assay as an evaluation tool of different aspirin dosing regimens in the clinical setting.
De Stefano V, Rocca B, Tosetto A, Soldati D, Petrucci G, Beggiato E, Bertozzi I, Betti S, Carli G, Carpenedo M, Cattaneo D, Cavalca V, Dragani A, Elli E, Finazzi G, Iurlo A, Lanzarone G, Lissandrini L, Palandri F, Paoli C, Rambaldi A, Ranalli P, Randi ML, Ricco A, Rossi E, Ruggeri M, Specchia G, Timillero A, Turnu L, Vianelli N, Vannucchi AM, Rodeghiero F, Patrono C. De Stefano V, et al. Among authors: bertozzi i. Blood Cancer J. 2018 Jun 1;8(6):49. doi: 10.1038/s41408-018-0078-3. Blood Cancer J. 2018. PMID: 29880847 Free PMC article. Clinical Trial.
A randomized double-blind trial of 3 aspirin regimens to optimize antiplatelet therapy in essential thrombocythemia.
Rocca B, Tosetto A, Betti S, Soldati D, Petrucci G, Rossi E, Timillero A, Cavalca V, Porro B, Iurlo A, Cattaneo D, Bucelli C, Dragani A, Di Ianni M, Ranalli P, Palandri F, Vianelli N, Beggiato E, Lanzarone G, Ruggeri M, Carli G, Elli EM, Carpenedo M, Randi ML, Bertozzi I, Paoli C, Specchia G, Ricco A, Vannucchi AM, Rodeghiero F, Patrono C, De Stefano V. Rocca B, et al. Among authors: bertozzi i. Blood. 2020 Jul 9;136(2):171-182. doi: 10.1182/blood.2019004596. Blood. 2020. PMID: 32266380 Free article. Clinical Trial.
Histology of the spleen in immune thrombocytopenia: clinical-pathological characterization and prognostic implications.
Pizzi M, Friziero A, Vianello F, Binotto G, Da Dalt G, Zoletto S, Carraro E, Fassan M, Sbaraglia M, Sperti C, Baldan N, D'Amore F, Bertozzi I, Righi S, Pierobon ES, Moletta L, Capovilla G, Grego A, Sabattini E, Fabris F, Merigliano S, Dei Tos AP. Pizzi M, et al. Among authors: bertozzi i. Eur J Haematol. 2021 Feb;106(2):281-289. doi: 10.1111/ejh.13547. Epub 2020 Dec 2. Eur J Haematol. 2021. PMID: 33190299
Association of Platelet Thromboxane Inhibition by Low-Dose Aspirin With Platelet Count and Cytoreductive Therapy in Essential Thrombocythemia.
Tosetto A, Rocca B, Petrucci G, Betti S, Soldati D, Rossi E, Timillero A, Cavalca V, Porro B, Iurlo A, Cattaneo D, Bucelli C, Dragani A, Di Ianni M, Ranalli P, Palandri F, Vianelli N, Beggiato E, Lanzarone G, Ruggeri M, Carli G, Elli EM, Priolo S, Randi ML, Bertozzi I, Loscocco GG, Ricco A, Specchia G, Vannucchi AM, Rodeghiero F, De Stefano V, Patrono C; Aspirin Regimens in EsSential thrombocythemia (ARES) Investigators. Tosetto A, et al. Among authors: bertozzi i. Clin Pharmacol Ther. 2022 Apr;111(4):939-949. doi: 10.1002/cpt.2485. Epub 2021 Nov 20. Clin Pharmacol Ther. 2022. PMID: 34743317 Free PMC article.
Survival and disease progression in essential thrombocythemia are significantly influenced by accurate morphologic diagnosis: an international study.
Barbui T, Thiele J, Passamonti F, Rumi E, Boveri E, Ruggeri M, Rodeghiero F, d'Amore ES, Randi ML, Bertozzi I, Marino F, Vannucchi AM, Antonioli E, Carrai V, Gisslinger H, Buxhofer-Ausch V, Müllauer L, Carobbio A, Gianatti A, Gangat N, Hanson CA, Tefferi A. Barbui T, et al. Among authors: bertozzi i. J Clin Oncol. 2011 Aug 10;29(23):3179-84. doi: 10.1200/JCO.2010.34.5298. Epub 2011 Jul 11. J Clin Oncol. 2011. PMID: 21747083
75 results